Vanguard Group
CRHM

Vanguard Group’s CRH Medical Corporation CRHM Stock Holding History

Vanguard Group’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,429
Closed -$69K – 4082
2017
Q3 		$69K Hold
26,429
– – ﹤0.01% 4011
2017
Q2 		$150K Buy
+26,429
New +$172K ﹤0.01% 3943

Other funds holding CRHM

Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group's CRHM Position: Q4 2017 in Review

Vanguard Group sold out of CRH Medical Corporation (CRHM) in Q4 2017, closing a stake of 26,429 shares — an estimated $69K sold.

Vanguard Group first reported a position in CRHM in Q2 2017 and held it in 2 quarters. The position peaked at $150K in Q2 2017. 40 funds tracked by Wall St. Rank hold CRHM as of Q4 2017.

  • Vanguard Group reported no remaining CRH Medical Corporation position as of Q4 2017 after selling out during the quarter.
  • Vanguard Group sold 26,429 CRH Medical Corporation shares in Q4 2017, an estimated $69K.
  • Vanguard Group first reported a position in CRH Medical Corporation in Q2 2017 and held it in 2 quarters.
  • Vanguard Group's CRH Medical Corporation position peaked at $150K in Q2 2017.
  • 40 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q4 2017.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.